Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(Peripheral neuropathy polyneuropathy )
29,960 results
  • Incidence and disease burden of chemotherapy-induced peripheral neuropathy in a population-based cohort. [Journal Article]
  • JNJ Neurol Neurosurg Psychiatry 2018 Feb 08
  • Shah A, Hoffman EM, … Staff NP
  • CONCLUSIONS: Results from our population-based study are consistent with previous reports of high incidence of CIPN in the first 2 years following incident exposure to neurotoxic chemotherapeutic agents, and its association with significant pain symptomatology and accompanied long-term opioid use. Increased survival following exposure to neurotoxic chemotherapy and its long-term disease burden necessitates further study among survivors.
  • IVIg for apparently autoimmune small-fiber polyneuropathy: first analysis of efficacy and safety. [Journal Article]
  • TATher Adv Neurol Disord 2018; 11:1756285617744484
  • Liu X, Treister R, … Oaklander AL
  • CONCLUSIONS: These results provide Class IV, real-world, proof-of-concept evidence suggesting that IVIg is safe and effective for rigorously selected SFPN patients with apparent autoimmune causality. They provide rationale for prospective trials, inform trial design and indirectly support the discovery of small-fiber-targeting autoimmune/inflammatory illnesses.
New Search Next